Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibikase Therapeutics (IKT) Change in Account Payables (2020 - 2026)

Inhibikase Therapeutics (IKT) has 7 years of Change in Account Payables data on record, last reported at $429251.0 in Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 36.95% to $429251.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$104746.0, a 122.13% decrease, with the full-year FY2025 number at $146827.0, down 45.98% from a year prior.
  • Change in Account Payables reached $429251.0 in Q1 2026 per IKT's latest filing, down from $537526.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for IKT hit a ceiling of $911832.0 in Q2 2025 and a floor of -$2.0 million in Q3 2025.
  • A 5-year average of $23814.6 and a median of $54248.0 in 2022 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 2415.21% in 2024 and fell as far as 1104.36% in 2024.
  • Tracing IKT's Change in Account Payables over 5 years: stood at $369950.0 in 2022, then tumbled by 123.73% to -$87794.0 in 2023, then crashed by 1104.36% to -$1.1 million in 2024, then surged by 150.84% to $537526.0 in 2025, then dropped by 20.14% to $429251.0 in 2026.
  • Business Quant data shows Change in Account Payables for IKT at $429251.0 in Q1 2026, $537526.0 in Q4 2025, and -$2.0 million in Q3 2025.